Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure:a phase Ⅲ, randomised, double-blind, placebo-controlled, multicentre trial
heart failure
2016-01-18(万方平台首次上网日期,不代表论文的发表时间)
共1页
281-281